World's best-selling medicine recalled after fake tablets found
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The prescription-only medicine is taken by 11 million people across Britain to reduce the risk of heart disease. The Medicines and Healthcare products Regulatory Agency (MHRA) is contacting all pharmacies across the country to alert them to withdraw the fake boxes of Lipitor, the world's best-selling medicine.
It is only the third time in a decade imitation medicine has entered the legitimate drug supply chain.
Custom officers confirmed they had intercepted fake pills in Rotterdam in May, leading to the MHRA recalling a batch of 120,000 Lipitor 20mg tablets bearing the number 004405K1, found to contain another statin that is not available in Britain.
It is not known how many patients may have been taking the false medication, but Nino Ahmed, head of intelligence at the MHRA, said: "Our testing of the counterfeit product indicates there is no immediate risk to patients. If patients have any concerns about side-effects they should discuss them with their doctor."
Pfizer, which manufactures the drug that brings in £12bn annually, urged the Government and European authorities to take more action to stop medicine fraud.
Kate Lloyd, medical director of Pfizer UK, said: "Patient safety is our top concern and we are seriously alarmed at the discovery of counterfeit medicine in the UK. Patient safety is at risk."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments